Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 9.0 | 0.0 | 0.0 | 9,094.8 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 18.0 | 0.0 | 0.0 | 18,189.7 |
| Gross profit | -9.0 | 0.0 | 0.0 | -9,094.8 |
| Gross margin | -100.0% | | | -100.0% |
| Research and development | | 8.4 | 5.1 | |
| General and administrative | 8.5 | 12.3 | 2.0 | 2,552.4 |
| EBIT | -17.5 | -20.7 | -7.1 | -11,647.3 |
| EBIT margin | -194.6% | | | -128.1% |
| Pre-tax income | -17.7 | -20.7 | -7.2 | -11,546.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -17.7 | -20.7 | -7.2 | -11,546.3 |
| Net margin | -196.5% | | | -127.0% |
| |
| Diluted EPS | ($1.56) | ($2.79) | | |
| Shares outstanding (diluted) | 11.3 | 7.4 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|